MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/dom.71210

Медицинская библиотека · Diabetes, obesity & metabolism · 2026

Stage-Adapted Disease-Modifying Therapy in Type 1 Diabetes.

Ye Chenming, Jin Zhenning, Hu Shen S

СтатьяОбзорПеревод пока не подготовлен

Аннотация

AIMS: To propose a stage-adapted framework for disease-modifying therapy in type 1 diabetes (T1D) that integrates immune plasticity and residual β-cell function, and to examine how these evolving constraints may inform treatment selection, combination strategies, and trial endpoints.

MATERIALS AND

METHODS

This narrative review synthesizes mechanistic, observational, and interventional evidence across presymptomatic T1D, recent-onset Stage 3 disease, and longer-duration Stage 3 disease. Evidence relating to immune modulation, antigen-specific intervention, β-cell protection, and β-cell replacement was interpreted according to disease stage and biological context.

RESULTS

Available evidence suggests that therapeutic responsiveness is shaped by two co-evolving constraints: immune plasticity and residual β-cell function. Early disease may provide a window in which autoreactive immunity can still be redirected and endogenous β-cell function preserved. In established disease, stabilized immune memory, reduced regulatory capacity, and substantial β-cell loss increasingly limit the effects of immune-directed intervention alone. Accordingly, immune-tolerance and β-cell-preservation strategies may have greater potential earlier in the disease course, whereas established disease may require β-cell replacement combined with graft protection and metabolic management.

CONCLUSIONS

Stage-adapted treatment matching provides a clinically interpretable framework rather than a validated treatment algorithm. Integrating disease stage with immune endotype, residual β-cell function, treatment feasibility, and stage-appropriate endpoints may improve the design and interpretation of disease-modifying trials and warrants prospective validation.

Для цитирования: Ye Chenming, Jin Zhenning, Hu Shen S. Stage-Adapted Disease-Modifying Therapy in Type 1 Diabetes.. Diabetes, obesity & metabolism. 2026. DOI: 10.1111/dom.71210.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.